When you start taking glutathione, do not expect to feel "transformed" the next morning
In the current study, investigators created modified neurons that lacked Orai1 channels
Your provider may recommend starting GLP-1 medications at lower doses, taking metformin with food, or adjusting timing to improve tolerability
An insightful overview of the anti-obesogenic effects produced by activation of thermogenesis in brown-fat tissues
While Mounjaros primary approval is for type 2 diabetes, its effectiveness in weight loss is significant, positioning it as an important option in diabetes care and weight management strategies
Details of the National Institutes of Health-funded study were published this week in a Nature paper titled A brain reward circuit inhibited by next-generation weight-loss drugs in mice. In it, the team reported that they investigated the small-molecule GLP-1s including Eli Lillys recently approved drug orforglipron, also known by the brand name Foundayo, as well as danuglipron, an oral GLP-1 that was being developed by Pfizer until the company decided to discontinue its development in 2025
